| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 1.10e-04 | 149 | 101 | 6 | GO:1990782 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | DLG5 FRAS1 TBX4 KIF26B LAMA5 FLG2 SETDB2 SETD2 CELSR1 DKK1 YAP1 DLG1 MACF1 FLRT3 CTNND1 EXOC4 | 8.17e-07 | 750 | 102 | 16 | GO:0048729 |
| GeneOntologyBiologicalProcess | kidney development | 2.33e-06 | 372 | 102 | 11 | GO:0001822 | |
| GeneOntologyBiologicalProcess | renal system development | 3.32e-06 | 386 | 102 | 11 | GO:0072001 | |
| GeneOntologyBiologicalProcess | epithelium development | CFH FLG DLG5 FRAS1 TBX4 KIF26B LAMA5 REN FLG2 KANK2 NCOR1 SETDB2 SETD2 CELSR1 DKK1 ZFP36L1 YAP1 KRT20 DLG1 FLRT3 CTNND1 | 8.49e-06 | 1469 | 102 | 21 | GO:0060429 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | DLG5 FRAS1 TBX4 KIF26B LAMA5 FLG2 SETDB2 SETD2 CELSR1 YAP1 DLG1 FLRT3 CTNND1 | 1.14e-05 | 619 | 102 | 13 | GO:0002009 |
| GeneOntologyBiologicalProcess | skin development | 1.61e-05 | 373 | 102 | 10 | GO:0043588 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CFH DLG5 KIF26B PKP4 PKD1L1 PCDHB12 MARCHF7 ITGB4 SLITRK1 CELSR1 CELSR2 ZFP36L1 DLG1 FLRT3 CTNND1 UBASH3B CX3CR1 | 2.02e-05 | 1077 | 102 | 17 | GO:0098609 |
| GeneOntologyBiologicalProcess | morphogenesis of a polarized epithelium | 3.08e-05 | 73 | 102 | 5 | GO:0001738 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | FRAS1 TBX4 LAMA5 SETDB2 SETD2 CELSR1 DKK1 ZFP36L1 YAP1 DLG1 MACF1 FLRT3 EXOC4 | 4.98e-05 | 713 | 102 | 13 | GO:0048598 |
| GeneOntologyBiologicalProcess | motor neuron migration | 5.12e-05 | 15 | 102 | 3 | GO:0097475 | |
| GeneOntologyBiologicalProcess | mesoderm development | 1.30e-04 | 157 | 102 | 6 | GO:0007498 | |
| GeneOntologyBiologicalProcess | skin epidermis development | 1.77e-04 | 166 | 102 | 6 | GO:0098773 | |
| GeneOntologyBiologicalProcess | nephron development | 2.28e-04 | 174 | 102 | 6 | GO:0072006 | |
| GeneOntologyCellularComponent | basement membrane | 3.15e-05 | 122 | 103 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | keratohyalin granule | 2.38e-04 | 5 | 103 | 2 | GO:0036457 | |
| GeneOntologyCellularComponent | postsynaptic density | 3.91e-04 | 451 | 103 | 9 | GO:0014069 | |
| GeneOntologyCellularComponent | female germ cell nucleus | 4.72e-04 | 31 | 103 | 3 | GO:0001674 | |
| GeneOntologyCellularComponent | asymmetric synapse | 5.86e-04 | 477 | 103 | 9 | GO:0032279 | |
| GeneOntologyCellularComponent | glutamatergic synapse | DLG5 FXR2 PI4K2A LAMA5 ABLIM3 ITGB4 SLITRK1 DLG1 PLAT FLRT3 PLCG1 CTNND1 | 6.87e-04 | 817 | 103 | 12 | GO:0098978 |
| GeneOntologyCellularComponent | cell leading edge | 8.19e-04 | 500 | 103 | 9 | GO:0031252 | |
| GeneOntologyCellularComponent | myelin sheath abaxonal region | 8.46e-04 | 9 | 103 | 2 | GO:0035748 | |
| GeneOntologyCellularComponent | growth cone membrane | 8.46e-04 | 9 | 103 | 2 | GO:0032584 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 8.54e-04 | 503 | 103 | 9 | GO:0099572 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.12e-03 | 523 | 103 | 9 | GO:0098984 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.23e-03 | 530 | 103 | 9 | GO:0062023 | |
| GeneOntologyCellularComponent | postsynapse | DLG5 FXR2 PKP4 GABRQ ITGB4 SLITRK1 DLG1 MACF1 PLAT EIF3A FLRT3 CTNND1 EXOC4 | 1.48e-03 | 1018 | 103 | 13 | GO:0098794 |
| GeneOntologyCellularComponent | extracellular matrix | 1.48e-03 | 656 | 103 | 10 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.52e-03 | 658 | 103 | 10 | GO:0030312 | |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 1.82e-03 | 49 | 103 | 3 | GO:0099092 | |
| MousePheno | abnormal visceral yolk sac mesenchyme morphology | 1.47e-06 | 36 | 77 | 5 | MP:0020516 | |
| MousePheno | abnormal visceral yolk sac blood island morphology | 2.72e-05 | 32 | 77 | 4 | MP:0011204 | |
| MousePheno | abnormal visceral yolk sac morphology | 4.52e-05 | 236 | 77 | 8 | MP:0001718 | |
| MousePheno | incomplete rostral neuropore closure | 4.66e-05 | 72 | 77 | 5 | MP:0000928 | |
| MousePheno | abnormal rostral neuropore morphology | 4.66e-05 | 72 | 77 | 5 | MP:0012543 | |
| MousePheno | abnormal embryonic growth/weight/body size | FLI1 DLG5 TBX4 PKD1L1 LAMA5 DDC FANCA JARID2 BPTF NCOR1 SETD2 ZFP36L1 YAP1 MTTP DLG1 FLRT3 PLCG1 AFF4 EXOC4 | 5.61e-05 | 1295 | 77 | 19 | MP:0002088 |
| MousePheno | abnormal neuropore morphology | 6.45e-05 | 77 | 77 | 5 | MP:0012542 | |
| MousePheno | abnormal tail morphology | FRAS1 SLC29A3 MTF2 LAMA5 MLLT10 CELSR1 PXDN DLG1 CX3CR1 AFF4 | 6.94e-05 | 403 | 77 | 10 | MP:0002111 |
| MousePheno | impaired branching involved in ureteric bud morphogenesis | 7.38e-05 | 41 | 77 | 4 | MP:0004936 | |
| MousePheno | retina gliosis | 8.55e-05 | 16 | 77 | 3 | MP:0009392 | |
| MousePheno | abnormal embryonic tissue morphology | DLG5 TBX4 LAMA5 MLLT10 DDC JARID2 BPTF SETD2 CELSR1 DKK1 ZFP36L1 YAP1 MTTP DLG1 MACF1 FLRT3 EXOC4 | 9.55e-05 | 1116 | 77 | 17 | MP:0002085 |
| MousePheno | abnormal branching involved in ureteric bud morphogenesis | 1.07e-04 | 45 | 77 | 4 | MP:0010981 | |
| MousePheno | abnormal extracellular matrix morphology | 2.23e-04 | 100 | 77 | 5 | MP:0013258 | |
| MousePheno | hemorrhage | CFH FLI1 DLG5 FRAS1 TBX4 MLLT10 FANCA JARID2 MTTP PLAT PLCG2 CX3CR1 | 2.57e-04 | 664 | 77 | 12 | MP:0001914 |
| MousePheno | abnormal megakaryocyte progenitor cell morphology | 2.63e-04 | 23 | 77 | 3 | MP:0002413 | |
| MousePheno | abnormal ureteric bud morphology | 2.69e-04 | 57 | 77 | 4 | MP:0006032 | |
| MousePheno | abnormal prenatal growth/weight/body size | FLI1 DLG5 TBX4 PKD1L1 LAMA5 DDC FANCA JARID2 BPTF NCOR1 SETD2 ZFP36L1 YAP1 MTTP DLG1 FLRT3 PLCG1 AFF4 EXOC4 | 3.66e-04 | 1493 | 77 | 19 | MP:0004196 |
| Domain | Calx_beta | 8.18e-06 | 8 | 100 | 3 | SM00237 | |
| Domain | Calx_beta | 1.22e-05 | 9 | 100 | 3 | IPR003644 | |
| Domain | Calx-beta | 1.22e-05 | 9 | 100 | 3 | PF03160 | |
| Domain | PLC-gamma | 2.84e-05 | 2 | 100 | 2 | IPR016279 | |
| Domain | Filaggrin | 2.84e-05 | 2 | 100 | 2 | IPR003303 | |
| Domain | SH3 | 1.62e-04 | 216 | 100 | 7 | PS50002 | |
| Domain | ConA-like_dom | 1.76e-04 | 219 | 100 | 7 | IPR013320 | |
| Domain | SH3_domain | 1.81e-04 | 220 | 100 | 7 | IPR001452 | |
| Domain | RDM_domain_RFPL | 2.81e-04 | 5 | 100 | 2 | IPR022723 | |
| Domain | RDM | 2.81e-04 | 5 | 100 | 2 | PF11002 | |
| Domain | EGF_LAM_2 | 5.44e-04 | 30 | 100 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 5.44e-04 | 30 | 100 | 3 | PS01248 | |
| Domain | Plakophilin/d_Catenin | 5.86e-04 | 7 | 100 | 2 | IPR028435 | |
| Domain | EGF_Lam | 8.61e-04 | 35 | 100 | 3 | SM00180 | |
| Domain | Laminin_EGF | 8.61e-04 | 35 | 100 | 3 | PF00053 | |
| Domain | GPS | 9.35e-04 | 36 | 100 | 3 | PS50221 | |
| Domain | GPS | 1.01e-03 | 37 | 100 | 3 | IPR000203 | |
| Domain | SH3 | 1.08e-03 | 216 | 100 | 6 | SM00326 | |
| Domain | LAM_G_DOMAIN | 1.10e-03 | 38 | 100 | 3 | PS50025 | |
| Domain | Laminin_EGF | 1.10e-03 | 38 | 100 | 3 | IPR002049 | |
| Pathway | WP_MESODERMAL_COMMITMENT_PATHWAY | 1.65e-05 | 153 | 75 | 7 | M39546 | |
| Pathway | WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2 | 7.71e-05 | 16 | 75 | 3 | M39484 | |
| Pubmed | 2.01e-07 | 209 | 102 | 8 | 36779422 | ||
| Pubmed | REPS1 GEMIN5 RFX1 BPTF NCOR1 SETD2 YAP1 DLG1 QSER1 CTNND1 EXOC4 | 6.70e-07 | 549 | 102 | 11 | 38280479 | |
| Pubmed | TCF4 TBX4 MTF2 BACH2 MLLT10 RFX1 ZC3H6 MXD4 JARID2 BPTF NCOR1 ZFP36L1 PLCG1 | 7.29e-07 | 808 | 102 | 13 | 20412781 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FRAS1 GBF1 REPS1 LAMA5 GEMIN5 MLLT10 ITGB4 MXD4 FANCA NCOR1 CELSR1 CELSR2 SBF2 PLCG1 ARHGAP21 | 8.15e-07 | 1105 | 102 | 15 | 35748872 |
| Pubmed | 8.50e-07 | 7 | 102 | 3 | 27609517 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.24e-06 | 361 | 102 | 9 | 26167880 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | ABCC1 PKP4 PI4K2A SNX33 FANCA USP31 YAP1 DLG1 MACF1 FLRT3 CTNND1 ARHGAP21 | 1.38e-06 | 719 | 102 | 12 | 35337019 |
| Pubmed | DLG5 REPS1 PKP4 LAMA5 GEMIN5 YTHDC2 PFKL KANK2 JARID2 SETD2 CELSR1 PXDN PLPP2 DLG1 MACF1 EIF3A AFF4 | 1.63e-06 | 1497 | 102 | 17 | 31527615 | |
| Pubmed | ABCC1 FXR2 LYSMD3 KANK2 FRMD4B SETD2 TEX264 CLMN YAP1 DLG1 QSER1 CTNND1 | 1.68e-06 | 733 | 102 | 12 | 34672954 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | GBF1 PI4K2A GEMIN5 YTHDC2 SNX33 RFX1 PITPNM1 BPTF NCOR1 SETD2 YAP1 DLG1 | 2.94e-06 | 774 | 102 | 12 | 15302935 |
| Pubmed | GEMIN5 MARCHF7 PFKL ABLIM3 ITGB4 TEX264 CLMN SBF2 DLG1 MACF1 PLCG1 QSER1 ARHGAP21 AFF4 | 3.49e-06 | 1084 | 102 | 14 | 11544199 | |
| Pubmed | 3.62e-06 | 216 | 102 | 7 | 31519766 | ||
| Pubmed | 4.35e-06 | 421 | 102 | 9 | 36976175 | ||
| Pubmed | FXR2 PKP4 ABLIM3 KANK2 NCOR1 CELSR2 DLG1 MACF1 QSER1 CTNND1 UBASH3B ARHGAP21 AFF4 | 4.99e-06 | 963 | 102 | 13 | 28671696 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 6.61e-06 | 565 | 102 | 10 | 25468996 | |
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 26989192 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TCF4 GBF1 SNX33 PFKL RFX1 KANK2 MXD4 BPTF NCOR1 RNASEL QSER1 CTNND1 | 8.24e-06 | 857 | 102 | 12 | 25609649 |
| Pubmed | Phospholipase C gamma 2 is essential for specific functions of Fc epsilon R and Fc gamma R. | 8.52e-06 | 2 | 102 | 2 | 12471105 | |
| Pubmed | The junctional epithelium originates from the odontogenic epithelium of an erupted tooth. | 8.52e-06 | 2 | 102 | 2 | 24785116 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 38925413 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 23292348 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 36909184 | ||
| Pubmed | Expression of DLG1 and DLG5 in the Intestinal Epithelium of Patients with CD. | 8.52e-06 | 2 | 102 | 2 | 27760079 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 17264675 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 33887196 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 34490521 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 15972651 | ||
| Pubmed | Extracellular proteolysis of reelin by tissue plasminogen activator following synaptic potentiation. | 8.52e-06 | 2 | 102 | 2 | 24892761 | |
| Pubmed | Molecular species of phospholipids in a murine stem-cell line responsive to erythropoietin. | 8.52e-06 | 2 | 102 | 2 | 8615781 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 38245803 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 25793864 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 24813994 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DLG5 GBF1 KIF26B USP31 ZFP36L1 CLMN YAP1 FAM83G MACF1 CTNND1 ARHGAP21 EXOC4 | 8.63e-06 | 861 | 102 | 12 | 36931259 |
| Pubmed | 9.77e-06 | 591 | 102 | 10 | 15231748 | ||
| Pubmed | PKP4 GEMIN5 YTHDC2 PFKL ABLIM3 KANK2 PITPNM1 USP31 CLMN DLG1 MACF1 EIF3A CTNND1 ARHGAP21 EXOC4 | 1.84e-05 | 1431 | 102 | 15 | 37142655 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | REPS1 GEMIN5 YTHDC2 PFKL SETD2 CLMN MACF1 EIF3A PLCG1 CTNND1 ARHGAP21 AFF4 | 1.93e-05 | 934 | 102 | 12 | 33916271 |
| Pubmed | 1.94e-05 | 18 | 102 | 3 | 14730302 | ||
| Pubmed | Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. | 1.94e-05 | 18 | 102 | 3 | 20064376 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 20538655 | ||
| Pubmed | Evolutionary forces shape the human RFPL1,2,3 genes toward a role in neocortex development. | 2.55e-05 | 3 | 102 | 2 | 18656177 | |
| Pubmed | Phospholipase Cγ2 plays a role in TCR signal transduction and T cell selection. | 2.55e-05 | 3 | 102 | 2 | 22837484 | |
| Pubmed | Dlg1, Sec8, and Mtmr2 regulate membrane homeostasis in Schwann cell myelination. | 2.55e-05 | 3 | 102 | 2 | 19587293 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 11331309 | ||
| Pubmed | GATA3 regulates FLG and FLG2 expression in human primary keratinocytes. | 2.55e-05 | 3 | 102 | 2 | 28928464 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 11677057 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 28786489 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 9592050 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 32437351 | ||
| Pubmed | Expression profile of Fc receptor-like molecules in patients with IgA nephropathy. | 2.55e-05 | 3 | 102 | 2 | 33597097 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 21732481 | ||
| Pubmed | Globular domains 4/5 of the laminin alpha3 chain mediate deposition of precursor laminin 5. | 2.55e-05 | 3 | 102 | 2 | 15316072 | |
| Pubmed | Anti-inflammatory genes associated with multiple sclerosis: a gene expression study. | 2.55e-05 | 3 | 102 | 2 | 25670004 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 17015722 | ||
| Pubmed | Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. | 2.55e-05 | 3 | 102 | 2 | 23403047 | |
| Pubmed | FLI1 induces erythroleukemia through opposing effects on UBASH3A and UBASH3B expression. | 2.55e-05 | 3 | 102 | 2 | 38461240 | |
| Pubmed | PLCγ-dependent mTOR signalling controls IL-7-mediated early B cell development. | 2.55e-05 | 3 | 102 | 2 | 29133930 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 20872577 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 11507676 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 10770799 | ||
| Pubmed | Expression of Fraser syndrome genes in normal and polycystic murine kidneys. | 2.55e-05 | 3 | 102 | 2 | 21993971 | |
| Pubmed | 4.07e-05 | 430 | 102 | 8 | 32581705 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CCDC14 DLG5 FXR2 BACH2 PKP4 PKD1L1 KANK2 NCOR1 FAM83G ARHGAP21 EXOC4 | 4.25e-05 | 853 | 102 | 11 | 28718761 |
| Pubmed | Mutation specific functions of EGFR result in a mutation-specific downstream pathway activation. | 4.92e-05 | 68 | 102 | 4 | 25754235 | |
| Pubmed | An important role of phospholipase Cgamma1 in pre-B-cell development and allelic exclusion. | 5.09e-05 | 4 | 102 | 2 | 15372077 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 18632669 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 20070863 | ||
| Pubmed | ESCRT machinery potentiates HIV-1 utilization of the PI(4,5)P(2)-PLC-IP3R-Ca(2+) signaling cascade. | 5.09e-05 | 4 | 102 | 2 | 21875593 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 15579904 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 21103407 | ||
| Pubmed | The armadillo protein p0071 regulates Rho signalling during cytokinesis. | 5.09e-05 | 4 | 102 | 2 | 17115030 | |
| Pubmed | The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation mechanisms. | 5.09e-05 | 4 | 102 | 2 | 37224017 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 18563433 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 27221712 | ||
| Pubmed | Action of TFII-I outside the nucleus as an inhibitor of agonist-induced calcium entry. | 5.09e-05 | 4 | 102 | 2 | 17023658 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 7774933 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 24101214 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 23082219 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 26464646 | ||
| Pubmed | A2E accumulation influences retinal microglial activation and complement regulation. | 5.09e-05 | 4 | 102 | 2 | 22819137 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 9398617 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 18378693 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 27780825 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 20679228 | ||
| Pubmed | Developmental expression profiles of Celsr (Flamingo) genes in the mouse. | 5.09e-05 | 4 | 102 | 2 | 11850187 | |
| Pubmed | Absence of erythrogenesis and vasculogenesis in Plcg1-deficient mice. | 5.09e-05 | 4 | 102 | 2 | 11744703 | |
| Pubmed | A single-cell time-lapse of mouse prenatal development from gastrula to birth. | 5.37e-05 | 25 | 102 | 3 | 38355799 | |
| Pubmed | 7.22e-05 | 75 | 102 | 4 | 15951569 | ||
| Pubmed | 7.81e-05 | 472 | 102 | 8 | 38943005 | ||
| Pubmed | FLG EML6 MYRIP SCML4 BPTF NCOR1 PXDN MTTP KRT20 DLG1 MACF1 ATG4C EIF3A ARHGAP21 | 8.18e-05 | 1442 | 102 | 14 | 35575683 | |
| Pubmed | 8.23e-05 | 242 | 102 | 6 | 34011540 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 2895697 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 18704934 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 20019092 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 20719962 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 16849395 | ||
| Pubmed | IRTAs: a new family of immunoglobulinlike receptors differentially expressed in B cells. | 8.47e-05 | 5 | 102 | 2 | 11929751 | |
| Pubmed | LAB: a new membrane-associated adaptor molecule in B cell activation. | 8.47e-05 | 5 | 102 | 2 | 12514734 | |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 9819383 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 10508838 | ||
| Pubmed | Spatiotemporal distribution of Fras1/Frem proteins during mouse embryonic development. | 8.47e-05 | 5 | 102 | 2 | 17251066 | |
| Interaction | C2CD4B interactions | 2.66e-06 | 44 | 101 | 5 | int:C2CD4B | |
| Interaction | WEE2-AS1 interactions | 1.81e-05 | 163 | 101 | 7 | int:WEE2-AS1 | |
| Interaction | LCK interactions | DLG5 TRIM35 PKP4 PFKL DLG1 MACF1 PLCG1 PLCG2 CTNND1 ARHGAP21 EXOC4 | 2.07e-05 | 463 | 101 | 11 | int:LCK |
| Interaction | C11orf52 interactions | 2.66e-05 | 311 | 101 | 9 | int:C11orf52 | |
| Interaction | AFDN interactions | 4.54e-05 | 333 | 101 | 9 | int:AFDN | |
| Interaction | LYN interactions | ABCC1 DLG5 KIF26B PKP4 KANK2 USP31 YAP1 DLG1 MACF1 PLCG1 PLCG2 CTNND1 ARHGAP21 | 6.26e-05 | 720 | 101 | 13 | int:LYN |
| Interaction | SIRPD interactions | 7.23e-05 | 86 | 101 | 5 | int:SIRPD | |
| Interaction | EPB41L4A interactions | 7.44e-05 | 140 | 101 | 6 | int:EPB41L4A | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 4.68e-05 | 3 | 72 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 4.68e-05 | 3 | 72 | 2 | 1189 | |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 3.24e-04 | 7 | 72 | 2 | 1350 | |
| GeneFamily | EF-hand domain containing | 1.80e-03 | 219 | 72 | 5 | 863 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 2.56e-03 | 19 | 72 | 2 | 832 | |
| GeneFamily | PDZ domain containing | 3.17e-03 | 152 | 72 | 4 | 1220 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 4.78e-03 | 26 | 72 | 2 | 904 | |
| GeneFamily | PHD finger proteins | 5.55e-03 | 90 | 72 | 3 | 88 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ABCC1 GBF1 MTF2 PKP4 MARCHF7 ABLIM3 JARID2 BPTF SETD2 DKK1 YAP1 DLG1 MACF1 EIF3A | 5.85e-06 | 856 | 102 | 14 | M4500 |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | 9.49e-06 | 265 | 102 | 8 | M1684 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | 1.15e-05 | 272 | 102 | 8 | MM1027 | |
| Coexpression | GSE22886_TH1_VS_TH2_48H_ACT_UP | 1.27e-05 | 198 | 102 | 7 | M4510 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_UP | 1.27e-05 | 198 | 102 | 7 | M5152 | |
| Coexpression | GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP | 1.36e-05 | 200 | 102 | 7 | M8625 | |
| Coexpression | GSE4984_UNTREATED_VS_LPS_TREATED_DC_UP | 2.83e-05 | 151 | 102 | 6 | M6498 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 3.72e-05 | 417 | 102 | 9 | M39224 | |
| Coexpression | GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN | 4.97e-05 | 167 | 102 | 6 | M361 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 7.53e-05 | 180 | 102 | 6 | M8239 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP | 8.50e-05 | 184 | 102 | 6 | M8544 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL | 8.84e-05 | 115 | 102 | 5 | M45752 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP | 9.57e-05 | 188 | 102 | 6 | MM983 | |
| Coexpression | BENPORATH_NANOG_TARGETS | GBF1 MARCHF7 MLLT10 RFX1 FANCA JARID2 NCOR1 KATNBL1 DKK1 ZFP36L1 YAP1 ATG4C EXOC4 | 1.20e-04 | 988 | 102 | 13 | M6616 |
| Coexpression | GSE22886_TCELL_VS_BCELL_NAIVE_DN | 1.27e-04 | 198 | 102 | 6 | M4426 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 1.31e-04 | 199 | 102 | 6 | M9180 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN | 1.34e-04 | 200 | 102 | 6 | M8088 | |
| Coexpression | GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP | 1.34e-04 | 200 | 102 | 6 | M8090 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_UP | 1.34e-04 | 200 | 102 | 6 | M9942 | |
| Coexpression | GSE17721_0.5H_VS_24H_CPG_BMDC_DN | 1.34e-04 | 200 | 102 | 6 | M4129 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_DN | 1.36e-04 | 126 | 102 | 5 | M9362 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | 1.44e-04 | 498 | 102 | 9 | M1741 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | 1.65e-04 | 507 | 102 | 9 | MM1030 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_DN | 1.88e-04 | 135 | 102 | 5 | MM753 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 2.01e-04 | 137 | 102 | 5 | M39241 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN | 2.15e-04 | 139 | 102 | 5 | M8948 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.62e-06 | 229 | 102 | 9 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | 2.77e-05 | 409 | 102 | 10 | gudmap_developingGonad_e12.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | CFH MTF2 PKP4 GEMIN5 REN PFKL LYSMD3 FRMD4B KATNBL1 RNASEL CLMN EIF3A UBASH3B CX3CR1 | 2.89e-05 | 801 | 102 | 14 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | TBX4 KIF26B TRIM35 BACH2 PCDHB12 MYRIP KANK2 DDC USP31 FLRT3 | 3.20e-05 | 416 | 102 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 4.40e-05 | 432 | 102 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_500 | 9.32e-05 | 152 | 102 | 6 | gudmap_developingGonad_e18.5_epididymis_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_500 | 9.75e-05 | 50 | 102 | 4 | gudmap_developingGonad_e14.5_ epididymis_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | CFH TBX4 MTF2 PKP4 YTHDC2 PFKL LYSMD3 FRMD4B SLITRK1 KATNBL1 RNASEL CLMN EIF3A | 1.25e-04 | 804 | 102 | 13 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#3_top-relative-expression-ranked_500 | 1.40e-04 | 103 | 102 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 1.49e-04 | 406 | 102 | 9 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_1000 | FLI1 TCF4 TBX4 KIF26B BACH2 PCDHB12 MYRIP DDC SLITRK1 NCOR1 DKK1 SLAIN1 FLRT3 | 1.65e-04 | 827 | 102 | 13 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 1.70e-04 | 413 | 102 | 9 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | 2.25e-04 | 429 | 102 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_500 | 2.56e-04 | 64 | 102 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k4 | |
| CoexpressionAtlas | lymph node | 3.14e-04 | 268 | 102 | 7 | lymph node | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | CFH PKP4 MYRIP GEMIN5 YTHDC2 LYSMD3 FRMD4B SLITRK1 KATNBL1 UNC13C PLCG2 UBASH3B | 3.23e-04 | 770 | 102 | 12 | gudmap_developingGonad_P2_ovary_1000 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.57e-10 | 194 | 103 | 9 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 1.36e-08 | 188 | 103 | 8 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.80e-08 | 195 | 103 | 8 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 2.11e-08 | 199 | 103 | 8 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | COPD-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 1.94e-07 | 178 | 103 | 7 | 441d1dba720141891b11f404744c59834d80e6c5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.01e-07 | 179 | 103 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.09e-07 | 180 | 103 | 7 | d8ef44710a77ad0fc03243428e5e1dc4d41200cb | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.91e-07 | 189 | 103 | 7 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.02e-07 | 190 | 103 | 7 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | COVID_vent-Lymphocytic-B_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.02e-07 | 190 | 103 | 7 | 40b5e9e8f8fd8d84cb5b43e67b49267082348e9f | |
| ToppCell | COVID_vent-Lymphocytic-B_cell-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.02e-07 | 190 | 103 | 7 | a37a32dc1b931562a6660074e19d5598efc65284 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 3.02e-07 | 190 | 103 | 7 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.35e-07 | 193 | 103 | 7 | ad2df9b77999780860141be6ec366afc0172a331 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.85e-07 | 197 | 103 | 7 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.85e-07 | 197 | 103 | 7 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.85e-07 | 197 | 103 | 7 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.85e-07 | 197 | 103 | 7 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.12e-07 | 199 | 103 | 7 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.26e-07 | 200 | 103 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-07 | 200 | 103 | 7 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 4.26e-07 | 200 | 103 | 7 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.26e-07 | 200 | 103 | 7 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-06 | 155 | 103 | 6 | 0e24e767a3895d31d34cabeaca0354aadae34e44 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-06 | 155 | 103 | 6 | f3489a548a2c0cc2d9117ff85865c6089ea0835d | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.84e-06 | 158 | 103 | 6 | d78e7e52657dc094430291fec07e9c298be9e584 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.05e-06 | 161 | 103 | 6 | b81b346309f3facbfbebd91cae4c5b33c7bd24ef | |
| ToppCell | Endothelial-endothelial_cell_of_bronchial_vessel|World / Lineage, Cell type, age group and donor | 2.37e-06 | 165 | 103 | 6 | 84e553d699ac56df89a77248f7308b9133e1b683 | |
| ToppCell | Control-B_cells-Activated_B_cells|Control / group, cell type (main and fine annotations) | 2.63e-06 | 168 | 103 | 6 | a7159a35fe37f8c241cf8d391debe271e0698105 | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 2.91e-06 | 171 | 103 | 6 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | Epithelial-basal_cell|World / Lineage, Cell type, age group and donor | 3.79e-06 | 179 | 103 | 6 | d9be6647ec7b22747dc00dce4ea307b6af412dfa | |
| ToppCell | Mesenchymal_cells-Stromal_fibro.|Mesenchymal_cells / Lineage and Cell class | 4.04e-06 | 181 | 103 | 6 | f8d914fdc06aaa75a4dc9158daf574ca28fa5432 | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.30e-06 | 183 | 103 | 6 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.72e-06 | 186 | 103 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.72e-06 | 186 | 103 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.87e-06 | 187 | 103 | 6 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-06 | 188 | 103 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.17e-06 | 189 | 103 | 6 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 5.33e-06 | 190 | 103 | 6 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.50e-06 | 191 | 103 | 6 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 5.66e-06 | 192 | 103 | 6 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | healthy_donor-Lymphocytic-B_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.66e-06 | 192 | 103 | 6 | 7d9e5772b6e531b50ed4e4d6304ef11235f27f37 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.66e-06 | 192 | 103 | 6 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.66e-06 | 192 | 103 | 6 | 89b8ebdc285ed3c0f807fd1157271130d37dfa41 | |
| ToppCell | healthy_donor-Lymphocytic-B_cell-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.66e-06 | 192 | 103 | 6 | 975312f9d6cede4d4f5b737e481e5c73accc8c50 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-06 | 193 | 103 | 6 | 54024a373e42e1c0bcc327dc084564b83b63a9d4 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-06 | 193 | 103 | 6 | 81d908594d2983ba7e7c1ec25afdde4315d9690e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.83e-06 | 193 | 103 | 6 | 2e72309607902dabe3218888b22a77fe941f3570 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.83e-06 | 193 | 103 | 6 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.83e-06 | 193 | 103 | 6 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.83e-06 | 193 | 103 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 5.83e-06 | 193 | 103 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.01e-06 | 194 | 103 | 6 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.01e-06 | 194 | 103 | 6 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.01e-06 | 194 | 103 | 6 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-06 | 194 | 103 | 6 | 74d0eaa76f6d9af14110dfe5b4bf9751b99ff6e3 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 6.19e-06 | 195 | 103 | 6 | 120296531bbc8080dcabacbd64733cc1dc34603a | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 6.19e-06 | 195 | 103 | 6 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|IPF / Disease state, Lineage and Cell class | 6.19e-06 | 195 | 103 | 6 | 2c3ad3cb79f11119ac69c413a938d21199145040 | |
| ToppCell | background-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.19e-06 | 195 | 103 | 6 | c7d60dabfc7cb310e002cab10003dadfcc34fe33 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 6.19e-06 | 195 | 103 | 6 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.19e-06 | 195 | 103 | 6 | 77e47d2e8b3eb7f7c9620369ccaf87581f923bdb | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.37e-06 | 196 | 103 | 6 | c5adab88140a465698abcbedc6505a43cae7bfd1 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.37e-06 | 196 | 103 | 6 | 5609b2d93172a488b35d854298a3a4e504e17e28 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 6.37e-06 | 196 | 103 | 6 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 6.37e-06 | 196 | 103 | 6 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.37e-06 | 196 | 103 | 6 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.37e-06 | 196 | 103 | 6 | 22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 6.37e-06 | 196 | 103 | 6 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.37e-06 | 196 | 103 | 6 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.37e-06 | 196 | 103 | 6 | 7af6c5147ac859353504d19727dbe24f63a29dd4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.37e-06 | 196 | 103 | 6 | 145fcf73deba9638b391a1af6c39fa205dc9829f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.37e-06 | 196 | 103 | 6 | adee900dcd16dbaba15c58bdcace09ba20214950 | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 6.56e-06 | 197 | 103 | 6 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.56e-06 | 197 | 103 | 6 | b0036cf3f7e6edf8e43f16cd2f0f0e80471d2576 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.56e-06 | 197 | 103 | 6 | d8355f07a53e771052f9ab6b38814365dfe8d9ae | |
| ToppCell | (6)_Endothelial-A_(Artery)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.75e-06 | 198 | 103 | 6 | 44f8cd5afa3685dcc8bfea0b15af5e8817e12e2e | |
| ToppCell | Bronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.75e-06 | 198 | 103 | 6 | f5b7013045b61fc56894f80092f799770dde1c8f | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.95e-06 | 199 | 103 | 6 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.95e-06 | 199 | 103 | 6 | c88a28a73f54dc571f2ff1e4b55073f83cbead2c | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Vein|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.95e-06 | 199 | 103 | 6 | cfb624c7728046fc7f3ef071f57e4d7b013f3fef | |
| ToppCell | 367C-Endothelial_cells-Endothelial-A_(Artery)|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.95e-06 | 199 | 103 | 6 | 29ed081bd5204a32068b420f2244f3704891547b | |
| ToppCell | 367C-Endothelial_cells-Endothelial-A_(Artery)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.95e-06 | 199 | 103 | 6 | c2d85f80037f209a4a329790f475d9f98f590262 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.15e-06 | 200 | 103 | 6 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / Treatment groups by lineage, cell group, cell type | 7.15e-06 | 200 | 103 | 6 | b036f5e22c95a3b14391785b6e91aa183b9bc9a8 | |
| ToppCell | Biopsy_Other_PF-Epithelial-KRT5-/KRT17+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 7.15e-06 | 200 | 103 | 6 | 077e6b9340686de9d0f11b035a8954e1f6a1b790 | |
| ToppCell | Neuronal-Inhibitory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.15e-06 | 200 | 103 | 6 | 9ff8647e2de0b538e15929dca88ebb20ff7ab043 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.15e-06 | 200 | 103 | 6 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 7.15e-06 | 200 | 103 | 6 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 7.15e-06 | 200 | 103 | 6 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.15e-06 | 200 | 103 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.15e-06 | 200 | 103 | 6 | 2554b77edfe3d378296b0b25625caacbfb1c0e76 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.15e-06 | 200 | 103 | 6 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.15e-06 | 200 | 103 | 6 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.15e-06 | 200 | 103 | 6 | a3b09580738783c6bff31ea33d5188912e56b8a7 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 7.15e-06 | 200 | 103 | 6 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.25e-05 | 129 | 103 | 5 | f83187c0bb06528127b8d2d56674ab1946846951 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-05 | 133 | 103 | 5 | 81189e8516a431d5890a0909f9fc7c82ec3442bc | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.56e-05 | 135 | 103 | 5 | 7743a01dc9c4542e910e7c0fe046004692a680bf | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.94e-05 | 154 | 103 | 5 | 020697ae8463b18f9b4270c404f52ce4c0e90135 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-midbrain/hindbrain_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.94e-05 | 154 | 103 | 5 | df1b58a20af73fa79c6c069c0117a9ffd85b476f | |
| Disease | lymphocyte count | FLI1 ABCC1 TCF4 FRAS1 SLC29A3 GBF1 BACH2 EML6 CPXCR1 DDC PREX2 SCML4 JARID2 NCOR1 SETD2 PLPP2 ZFP36L1 HFM1 UBASH3B CX3CR1 | 7.21e-08 | 1464 | 99 | 20 | EFO_0004587 |
| Disease | C-reactive protein measurement | TCF4 MTF2 ZBTB9 YTHDC2 MLLT10 KANK2 FANCA BPTF NCOR1 PXDN CELSR2 MACF1 HFM1 QSER1 ARHGAP21 AFF4 | 2.55e-06 | 1206 | 99 | 16 | EFO_0004458 |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.25e-05 | 49 | 99 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | urinary albumin to creatinine ratio | 3.22e-05 | 179 | 99 | 6 | EFO_0007778 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 4.15e-05 | 276 | 99 | 7 | EFO_0004612, EFO_0020943 | |
| Disease | glycoprotein measurement | 5.18e-05 | 119 | 99 | 5 | EFO_0004555 | |
| Disease | hemoglobin A1 measurement | 6.50e-05 | 520 | 99 | 9 | EFO_0007629 | |
| Disease | response to perphenazine | 9.01e-05 | 26 | 99 | 3 | GO_0097334 | |
| Disease | grip strength measurement | 1.82e-04 | 350 | 99 | 7 | EFO_0006941 | |
| Disease | colorectal cancer (is_marker_for) | 1.91e-04 | 157 | 99 | 5 | DOID:9256 (is_marker_for) | |
| Disease | Leukemia, Myelocytic, Acute | 3.00e-04 | 173 | 99 | 5 | C0023467 | |
| Disease | Embryonal Rhabdomyosarcoma | 3.08e-04 | 8 | 99 | 2 | C0206656 | |
| Disease | Vitiligo | 3.79e-04 | 101 | 99 | 4 | EFO_0004208 | |
| Disease | QT interval | 4.43e-04 | 534 | 99 | 8 | EFO_0004682 | |
| Disease | monocyte count | FLI1 TCF4 MTF2 FXR2 MARCHF7 MLLT10 MXD4 PREX2 FANCA SETD2 HFM1 UBASH3B CX3CR1 | 4.69e-04 | 1320 | 99 | 13 | EFO_0005091 |
| Disease | Fuchs endothelial corneal dystrophy | 4.93e-04 | 10 | 99 | 2 | Orphanet_98974 | |
| Disease | overall survival, pancreatic carcinoma | 6.03e-04 | 49 | 99 | 3 | EFO_0000638, EFO_0002618 | |
| Disease | serum alanine aminotransferase measurement | 6.84e-04 | 869 | 99 | 10 | EFO_0004735 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 7.85e-04 | 447 | 99 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | total blood protein measurement | 8.06e-04 | 449 | 99 | 7 | EFO_0004536 | |
| Disease | mood disorder | 8.48e-04 | 13 | 99 | 2 | EFO_0004247 | |
| Disease | celiac disease | 8.72e-04 | 126 | 99 | 4 | EFO_0001060 | |
| Disease | multiple sclerosis | 8.85e-04 | 594 | 99 | 8 | MONDO_0005301 | |
| Disease | serum gamma-glutamyl transferase measurement | DLG5 REPS1 MTF2 BPTF SETD2 CELSR2 PLCG1 UBASH3B ARHGAP21 EXOC4 | 1.00e-03 | 914 | 99 | 10 | EFO_0004532 |
| Disease | hair colour measurement | 1.11e-03 | 615 | 99 | 8 | EFO_0007822 | |
| Disease | hepcidin:transferrin saturation ratio | 1.14e-03 | 15 | 99 | 2 | EFO_0007902 | |
| Disease | disease progression measurement | 1.14e-03 | 61 | 99 | 3 | EFO_0008336 | |
| Disease | myeloid white cell count | 1.21e-03 | 937 | 99 | 10 | EFO_0007988 | |
| Disease | sleep duration | 1.41e-03 | 362 | 99 | 6 | EFO_0005271 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.45e-03 | 364 | 99 | 6 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | acute kidney failure (is_marker_for) | 1.47e-03 | 17 | 99 | 2 | DOID:3021 (is_marker_for) | |
| Disease | Age-related macular degeneration | 1.65e-03 | 18 | 99 | 2 | cv:C0242383 | |
| Disease | C-C motif chemokine 3 measurement | 1.65e-03 | 18 | 99 | 2 | EFO_0008051 | |
| Disease | Hemorrhage | 2.04e-03 | 20 | 99 | 2 | C0019080 | |
| Disease | status epilepticus (implicated_via_orthology) | 2.24e-03 | 21 | 99 | 2 | DOID:1824 (implicated_via_orthology) | |
| Disease | skin hydration measurement | 2.24e-03 | 21 | 99 | 2 | EFO_0009586 | |
| Disease | portal hypertension (biomarker_via_orthology) | 2.46e-03 | 22 | 99 | 2 | DOID:10762 (biomarker_via_orthology) | |
| Disease | nephrosis (biomarker_via_orthology) | 2.46e-03 | 22 | 99 | 2 | DOID:2527 (biomarker_via_orthology) | |
| Disease | response to selective serotonin reuptake inhibitor | 2.68e-03 | 82 | 99 | 3 | EFO_0005658 | |
| Disease | non-high density lipoprotein cholesterol measurement | 2.78e-03 | 713 | 99 | 8 | EFO_0005689 | |
| Disease | neuroimaging measurement, brain volume measurement | 2.81e-03 | 286 | 99 | 5 | EFO_0004346, EFO_0006930 | |
| Disease | Lynch syndrome (is_implicated_in) | 2.93e-03 | 24 | 99 | 2 | DOID:3883 (is_implicated_in) | |
| Disease | Autism Spectrum Disorders | 2.96e-03 | 85 | 99 | 3 | C1510586 | |
| Disease | neuroimaging measurement | TCF4 RELN KIF26B MLLT10 FRMD4B NCOR1 CELSR1 MACF1 QSER1 EXOC4 | 3.16e-03 | 1069 | 99 | 10 | EFO_0004346 |
| Disease | Involutional paraphrenia | 3.18e-03 | 25 | 99 | 2 | C1571983 | |
| Disease | Psychosis, Involutional | 3.18e-03 | 25 | 99 | 2 | C1571984 | |
| Disease | Involutional Depression | 3.18e-03 | 25 | 99 | 2 | C0011574 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DSLTGLRSSYASQHS | 381 | Q99569 | |
| RSSTSSREALHTAGY | 546 | O94929 | |
| SSHSTSGFASTFRED | 246 | Q9BYV9 | |
| HVTSNASDSESSYRG | 681 | Q12959 | |
| NHSESSSNRSYRDSG | 626 | Q9NZU0 | |
| SVLSSNFTYHTSDGD | 336 | P49238 | |
| INSSRSSQESYAHGT | 881 | P08603 | |
| LSLDEQSSSYASSHS | 2811 | Q9NYQ6 | |
| LEDDQSGSYASTHSS | 2726 | Q9HCU4 | |
| SESASRNHYGSAREQ | 1611 | P20930 | |
| DSSRHSASQYGQDTI | 3096 | P20930 | |
| FSSLSQDSAYHSGIQ | 3931 | P20930 | |
| YSSDQAHSSVERAGL | 186 | P20711 | |
| SHLLSSSDAEGNYRD | 1611 | Q12830 | |
| FNADSGYSIHSDSES | 86 | Q49A88 | |
| GHSRDYDFTSTTTNE | 421 | Q96DT6 | |
| HDRESYNNSGSSSRK | 151 | Q9UHB7 | |
| NTYSELRQHSCSSSG | 286 | Q8N123 | |
| TSSSISRHYGLSDSR | 466 | Q9Y483 | |
| DLSSVSQSQSYSSGH | 416 | Q2KHR3 | |
| LGVYLSSAATRNSHS | 256 | Q15622 | |
| YGSSLDTTSSTIHNN | 116 | A0A2R8YFM6 | |
| ANHYSSDSQLSAGLT | 366 | A5PLL1 | |
| TGRRSSGHSEYSDSE | 1796 | Q5D862 | |
| HDSRTYLVNSSDSGS | 116 | Q9H079 | |
| SYSHDGSNSLKDRFT | 2386 | Q86XX4 | |
| SSSDADDHYSLQSGT | 176 | Q14582 | |
| GRQTSRHSSVQYSSE | 126 | Q7Z3D4 | |
| TDESSSSSLHATRTY | 411 | P51116 | |
| AGKDHSASFSNSSYL | 1291 | Q86WG5 | |
| SDLPSTSEQARHSYG | 451 | Q9UN88 | |
| ERLSYPSHSSADINS | 261 | P15884 | |
| AHLSSDPDYSSSSEQ | 846 | Q2KJY2 | |
| VAHNYDRFSRSGSSS | 601 | P55157 | |
| SETTARTYSHLNIAG | 146 | P17858 | |
| SDYSEMRATHGSNSL | 1241 | Q8TDM6 | |
| SHNTYLTGDQLRSES | 326 | P16885 | |
| TTRDSYQFGGSLSSH | 3336 | O15230 | |
| DVTEARLSFYSGHSS | 156 | O43688 | |
| ISNSRHTVNYGSDLT | 46 | P35900 | |
| DYNSLTRSEHSHSTT | 1491 | P16144 | |
| TSHAVSGSSRYDSNE | 561 | Q68CR7 | |
| SHFQSLSYSLAERSS | 4091 | Q9UPN3 | |
| SGTNSELSYTFSHAS | 271 | Q9Y5F1 | |
| ISESFGSSRLSSYHN | 711 | P78509 | |
| SAYSNDNELDSHIGS | 176 | A2PYH4 | |
| VETARSHQRSSSESY | 451 | Q9BTU6 | |
| RNAYSSSHLEPESSS | 671 | Q9Y2L6 | |
| HYSTAGSSSVREINL | 246 | Q96A65 | |
| HTSRTLSFGSDLNYA | 486 | Q14152 | |
| SFNLSLTEEHSGNYS | 261 | Q96LA6 | |
| DSSEAYANHSSSFIG | 81 | O15360 | |
| AYNTTSHTDQSSRLS | 201 | Q01543 | |
| SFNLSLTAEHSGNYS | 436 | Q96P31 | |
| SSLNDTYHSRDSSFR | 31 | Q9H992 | |
| DSSISNLMDYSHRSG | 151 | Q9H992 | |
| SHRSGDFTTSSYVQD | 161 | Q9H992 | |
| HQNDVSLDRGYTSDS | 1306 | Q92538 | |
| SLCSNASGDSRHSAY | 86 | Q63ZY3 | |
| NLSTGSQSFYLEHTD | 1401 | Q6ZMW3 | |
| SSRHSEAGSEYTVVS | 866 | D6RIA3 | |
| DHSTLDGYSRRTTLS | 161 | O94907 | |
| SSSSHVYSREGEFTV | 636 | Q8TDX9 | |
| ASRSQSSHSYDDSTL | 856 | O60716 | |
| SSARYGSHDGSSTVA | 1106 | Q92833 | |
| SSSSYSGDISRHHNS | 916 | P33527 | |
| DYVTLSDQDSHSGSS | 586 | A6ND36 | |
| SYQHGRDQTTTSDTF | 901 | P0C091 | |
| EDDFQHSSNSTYRTT | 6 | Q9BZD2 | |
| SVSDDLTSVTNHGYR | 316 | Q9UPQ4 | |
| NEQESRHAASYSSDS | 106 | Q96D71 | |
| RHAASYSSDSENQGS | 111 | Q96D71 | |
| LGSASQSYSHTTRAS | 421 | P22670 | |
| DASDSSSYKHNGTEL | 131 | P00797 | |
| DSSSSLSSHRYETPS | 1956 | O75376 | |
| SRENSHLVTFYGSES | 411 | Q05823 | |
| SEALNSAISHTGRTY | 436 | Q8WV41 | |
| RQDYASTSASVSRHS | 286 | Q8ND83 | |
| LHNSEIGSSSYSRIS | 541 | Q96KW2 | |
| SYDQSLSDSSSHSQD | 211 | P55197 | |
| SFTDSDLRNDSYSHS | 376 | P55197 | |
| DLRNDSYSHSQQSSA | 381 | P55197 | |
| SDYSIPSRTSHSDSS | 896 | Q96JQ2 | |
| LSPYSHDGDSLSRSQ | 496 | O00562 | |
| DQEGYLSSSSSSHSG | 301 | Q07352 | |
| SSSNLSYQSHDCSGA | 136 | Q96T68 | |
| SAYRGTHSLTESGAS | 221 | P00750 | |
| KHNSPSSDDSSDYSL | 71 | P61129 | |
| ASGDRSHYSDSQLSL | 636 | Q8NB66 | |
| DTYSRGHDSSSQSDH | 726 | Q8N7X1 | |
| ETGTHSNSYLDTSRV | 601 | Q96PX8 | |
| SSYHEANGNSVRSTS | 991 | Q5VZP5 | |
| YTLFSASSEGQNHSR | 321 | Q8TEQ6 | |
| DASNVYGSTEHEARS | 911 | Q92626 | |
| LNSGTYHSRDESTDS | 386 | P46937 | |
| YHSRDESTDSGLSMS | 391 | P46937 | |
| DTRSEHSYSESGASG | 256 | Q9Y6I9 | |
| ISSSHNTYLTGDQFS | 331 | P19174 | |
| DSGHDTISNRDSYSD | 1096 | Q70Z35 | |
| DAESGSHVYTFRSVS | 321 | O75678 | |
| AESGSHVYTFRSVSA | 261 | O75679 | |
| TSSYQEGRRAHEATS | 126 | Q6ZWC4 | |
| DGYSSENTSRAHTPL | 1841 | Q9BYW2 | |
| RGGNSYHALLSTTSS | 151 | Q96C00 | |
| NVSVDYRHSETSATA | 496 | Q9H6S0 | |
| TFSLSRESSLQYHSG | 521 | P57082 | |
| HGSYSILNTSSSNSL | 326 | Q8TF42 | |
| RNLSSSYQEPSDSHS | 916 | Q70CQ4 | |
| YSGHSDGISSSRSQA | 351 | Q5T5U3 | |
| YSVDTSASTFNHRGS | 246 | Q8N228 | |
| QGSTAYSSRSSAAHR | 41 | P52179 | |
| ISGSDSTFYRQSEGH | 171 | Q8NFW9 |